Ipsilateral silent period: A marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?

被引:31
|
作者
Jung, Patrick
Beyerle, Astrid
Hurnpich, Marek
Neumann-Haefelin, Tobias
Lanfermann, Heinrich
Ziemann, Ulf
机构
[1] Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany
[2] Univ Frankfurt, Inst Neuroradiol, D-6000 Frankfurt, Germany
关键词
ipsilateral silent period; central motor conduction time; transcranial magnetic stimulation; corpus callosuni; relapsing-remitting multiple sclerosis;
D O I
10.1016/j.jns.2006.08.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The corpus callosum (CC) is commonly affected in multiple sclerosis (MS). The ipsilateral silent period (iSP) is a putative electrophysiological marker of callosal demyelination. The purpose of this study was to re-assess, under recently established optimised protocol conditions [Jung P., Ziemann U. Differences of the ipsilateral silent period in small hand muscles. Muscle Nerve in press.], its diagnostic sensitivity in MS, about which conflicting results were reported in previous studies. Methods: ISP measurements (onset, duration, and depth) were obtained in the abductor pollicis brevis (APB) muscle of either hand in 49 patients with early relapsing-remitting MS (RRMS) (mean EDSS, 1.3). Standard central motor conduction times to the APB (CMCTAPB) and tibial anterior muscles (CMCTTA), and magnetic resonance images (MRI) were also obtained. Results: ISP measurements showed a similar diagnostic sensitivity (28.6%) as CMCTAPB (24.5%), while diagnostic sensitivities of CMCTTA (69.4%) and MRI of the CC (78.6%) were much higher. Prolongation of iSP duration was the most sensitive single iSP measure. ISP prolongation occurred more frequently when CMCTAPB to the same hand was also prolonged (40.0% vs. 8.4%, p < 0.000 1). The correlation between iSP duration and CMCTAPB was significant (Pearson's r=0.24, p < 0.02), suggesting that iSP duration can be contaminated by demyclination of the contralateral corticospinal tract. ISP duration did not correlate with MRI abnon-nalities of the CC. Conclusions: ISP measures are neither a sensitive nor a specific marker of callosal conduction abnormality in early RRMS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [1] The ipsilateral silent period: an early diagnostic marker of callosal disconnection in ALS
    Hubers, Annemarie
    Kassubek, Jan
    Mueller, Hans-Peter
    Broc, Nicolas
    Dreyhaupt, Jens
    Ludolph, Albert C.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [2] Circadian Activity Rhythm in Early Relapsing-Remitting Multiple Sclerosis
    Tonetti, Lorenzo
    Camilli, Federico
    Giovagnoli, Sara
    Natale, Vincenzo
    Lugaresi, Alessandra
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [3] Measuring productivity loss in early relapsing-remitting multiple sclerosis
    Sainz de la Maza, Susana
    Maurino, Jorge
    Borges, Monica
    Martin-Martinez, Jesus
    Sotoca, Javier
    Alonso, Ana
    Caminero, Ana B.
    Borrega, Laura
    Sanchez-Menoyo, Jose L.
    Barrero-Hernandez, Francisco J.
    Calles, Carmen
    Brieva, Luis
    Blasco, Maria R.
    Dotor Garcia-Soto, Julio
    del Campo-Amigo, Maria
    Navarro-Canto, Laura
    Aguera, Eduardo
    Garces, Moises
    Carmona, Olga
    Gabaldon-Torres, Laura
    Forero, Lucia
    Hervas, Mariona
    Ruiz de Alda, Lucia
    Gomez-Ballesteros, Rocio
    Castillo-Trivino, Tamara
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [4] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [5] Central motor conduction differs between acute relapsing-remitting and chronic progressive multiple sclerosis
    Humm, AM
    Magistris, MR
    Truffert, A
    Hess, CW
    Rösler, KM
    CLINICAL NEUROPHYSIOLOGY, 2003, 114 (11) : 2196 - 2203
  • [6] Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis
    Zhuo, Zhizheng
    Zhang, Ningnannan
    Ao, Feng
    Hua, Tiantian
    Duan, Yunyun
    Xu, Xiaolu
    Weng, Jinyuan
    Cao, Guanmei
    Li, Kuncheng
    Zhou, Fuqing
    Li, Haiqing
    Li, Yongmei
    Han, Xuemei
    Haller, Sven
    Barkhof, Frederik
    Hu, Geli
    Shi, Fudong
    Zhang, Xinghu
    Tian, Decai
    Liu, Yaou
    EUROPEAN RADIOLOGY, 2025, 35 (03) : 1228 - 1241
  • [7] An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
    Saleem, Sidra
    Anwar, Arsalan
    Fayyaz, Muniba
    Anwer, Fatima
    Anwar, Faria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [8] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [9] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [10] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762